Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical Trials
比美珠单抗治疗化脓性汗腺炎患者的疼痛疗效：BE HEARD I&II 期 3 期随机临床试验的 48 周汇总结果
期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-025-00779-7
Ingram, John R; Fujita, Hideki; Gottlieb, Alice B; Lev-Tov, Hadar; Prens, Errol; Sayed, Christopher J; Shi, Vivian Y; Szepietowski, Jacek C; Takahashi, Kenzo; Frew, John W; Lambert, Jérémy; Davis, Leah; Oh, Tae; Rolleri, Robert; Saintmard, Marie-Hélène; Orenstein, Lauren A V
